The PlexusDx Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, and 151 genetic insights including IGF1 rs35767 to provide a comprehensive view of how your genetics may influence these interconnected systems
Some patients may tolerate one route better than another, but route alone does not eliminate side effect risk
symptoms may be relegated to being an "annoyance" without being debilitating
EMA decision anticipated June 2026 Why It Matters: Adherence remains a key barrier in LDL-C management with statins and injectables LEROCHOL introduces meaningful differentiation versus Repatha and Praluent, particularly on storage and usability Expands access to potent lipid lowering for high-risk cardiovascular patients Key Takeaway: LEROCHOL strengthens the PCSK9 landscape with a long-acting, patient-friendly biologicraising the bar on convenience while intensifying competition in cardiovascular risk reduction
TRIUMPH-1 Phase 3 Trial Results Revolutionary Findings for Retatrutide Weight Loss in Gardner In May 2026, the TRIUMPH-1 trial showcased outstanding results for Retatrutide, with patients losing significant weight at various dosages
11 Every meal and snack should be viewed as an opportunity to provide the body with the essential building blocks it needs to function optimally, support fat loss, and preserve vital muscle tissue
